Jim Simons Vaxxinity, Inc. Transaction History

Renaissance Technologies LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.62 - $0.86 $21,762 - $30,186	35,100 New	35,100 $25,000
Q4 2022 Feb 13, 2023	SELL	$1.31 - $2.62 $99,613 - $199,227	-76,041 Reduced 41.41%	107,594 $151,000
Q3 2022 Nov 14, 2022	SELL	$1.64 - $2.48 $129,174 - $195,337	-78,765 Reduced 30.02%	183,635 $364,000
Q2 2022 Aug 12, 2022	BUY	$1.55 - $6.95 $406,720 - $1.82 Million	262,400 New	262,400 $412,000

469K

Ticker VAXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 112,150,000
Market Cap $1.12M
Description
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.